Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gambro's figures herald end of restructuring

This article was originally published in Clinica

Executive Summary

Swedish dialysis company Gambro's first-quarter results showed improved operating margin and earnings. The operating margin was 18.4%, down from the 19.3% in 1998's first quarter, but up sharply from the last quarter figure of 15.5%. The company had operating earnings of SKr905 million ($120 million), compared with SKr858 million in the previous first quarter. Sales were SKr4.92 billion, up from SKr4.45 billion. The company says the results signify a turnaround - it has been burdened by significant restructuring costs (see Clinica No 843, p 9).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel